Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Unknown 3Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 80Rectal Neoplasms 40Colonic Neoplasms 34Pancreatic Neoplasms 27Stomach Neoplasms 22Carcinoma, Hepatocellular 21Breast Neoplasms 21Neoplasm Metastasis 19Esophageal Neoplasms 19Nasopharyngeal Carcinoma 15Esophageal Squamous Cell Carcinoma 13Neoplasms 7Head and Neck Neoplasms 7Liver Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Squamous Cell 5Anus Neoplasms 5Nasopharyngeal Neoplasms 4Inflammatory Breast Neoplasms 4Cholangiocarcinoma 4Adenocarcinoma Of Esophagus 4Recurrence 3Gallbladder Neoplasms 3Digestive System Neoplasms 3Breast Neoplasms, Male 3Bile Duct Neoplasms 3Solid Tumors 2Ovarian Neoplasms 2Neutropenia 2Neoplasms, Unknown Primary 2

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Recurrence × Fluorouracil × Clear all
NCT02523053 2016-10-21

Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients

Eastern Hepatobiliary Surgery Hospital

Phase NA Unknown
160 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT01125020 2010-05-18

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

Shanghai Jiao Tong University School of Medicine

Phase NA Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡